Posted Friday June 27, 2008, 7:34 am, Over one day old
About 40% of New York City residents who have multiple sex partners did not use a condom during their last sexual encounter, according to a report released Tuesday by the New York City Department of Health and Mental Hygiene, the
Read 40% Of NYC Residents With Multiple Sex Partners Engaged In Sex Without Condoms, Report Finds (Links)
Posted Friday June 27, 2008, 7:34 am, Over one day old
Good Samaritan Hospital announced that it has been recognized in the top 5 percent for women's health services based on a study by HealthGrades, the nation's leading independent health care ratings company. The HealthGrades Fifth Annual Report on Women's Health Outcomes in U.S.
Read Good Samaritan Hospital In The Top 5% In Women's Health According To HealthGrades(R) Study (Links)
Posted Thursday June 26, 2008, 5:34 am, Over one day old
House Democratic leaders on Tuesday "abruptly pulled" a bill (HR 5876) related to child abuse in residential treatment programs after Republican leaders sought to amend the measure to require parental consent before new prescriptions were given, including those for contraception, Roll Call reports.
Read House Democrats Pull Bill After GOP Seeks Parental Consent For Contraception (Links)
Posted Thursday June 26, 2008, 5:34 am, Over one day old
Bayer Schering on Tuesday announced that it has entered into two agreements with Barr Pharmaceuticals to supply Barr with generic versions of its oral contraceptives Yasmin and YAZ to market in the U.S., the
Read Bayer, Barr Sign Agreements For Generic Version Of Oral Contraceptives Yasmin, YAZ (Links)
Posted Thursday June 26, 2008, 5:34 am, Over one day old
Many states are opting out of funding from the federal Title V abstinence education program amidst "doubts that the program works" and "frustrat[ion] by chronic uncertainty that Congress will continue to fund the program," the AP/Google.com reports. According to the AP/Google.
Read More States Opting Out Of Title V Abstinence-Only Education Funding, The AP/Google.com Reports (Links)
Posted Thursday June 26, 2008, 5:34 am, Over one day old
Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, announced that it has submitted a 510(k) pre-market notification application to the U.S. Food & Drug Administration (FDA) requesting regulatory clearance of its Ovarian Tumor Triage Test known as OVA1(TM).
Read Vermillion Files 510(k) Application With U.S. Food & Drug Administration For OVA1 Ovarian Tumor Triage Test (Links)
Posted Thursday June 26, 2008, 5:34 am, Over one day old
Read Women's Heart Health: Fact Sheet (Links)